Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe study's locations list has been trimmed from 13 to 9 sites, removing several U.S. locations (Nashville, OKC, New York, and Los Angeles) and updating the total site count. A new revision tag, v3.6.3, was posted.SummaryDifference0.7%

- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page or site framework. This change affects display/versioning rather than the study data or eligibility details.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page adds a recruitment notice ('No longer looking for participants') and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header is reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updates to v3.6.0.SummaryDifference0.3%

- Check39 days agoChange DetectedNew revision entries were added for v3.5.5 dated 2026-06-02 and 2026-05-29. Older revision entries for v3.5.4 dated 2026-05-07 and 2026-05-05 were removed.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision label on the page updated to v3.5.4 from v3.5.3, indicating a new version of the page content.SummaryDifference0.0%

- Check67 days agoChange DetectedNew site entry 'Research Site' added on 2026-05-07 to the study's list of participating locations, and a number of established centers were removed (e.g., The Angeles Clinic, UCLA Hematology Oncology, NYU Cancer Institute, Memorial Sloan Kettering, MD Anderson, START San Antonio, UW Carbone Cancer Center). These changes alter where patients can enroll and who is involved in the ARC-8 trial.SummaryDifference0.7%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.